9783527337750 - fragment-based drug discovery: lessons and outlook (methods and principles in medicinal chemistry) (2 Ergebnisse)

Zustand: New. In.

Zustand: New. Daniel A. Erlanson is the co-founder and President of Carmot Therapeutics, Inc., which is developing fragment-based approaches to address unmet needs in drug discovery. Prior to Carmot, Dr. Erlanson worked in medicinal chemistry and technology development a.